OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Contemporary OB/GYN. All rights reserved.
Protocols for High-Risk Pregnancies, 7th Edition: Protocol 18 - Peripartum Cardiomyopathy
Sarah Rae Easter
Departments of Obstetrics and Gynecology, and Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Carolyn Zelop, MD
Dr. Zelop is Director of Ultrasound, Fetal Echocardiography and Perinatal Research at Valley Hospital in Ridgewood, New Jersey, and clinical professor of obstetrics and gynecology at NYU School of Medicine, New York. She works actively with ACOG and the A
Protocol 18: Peripartum Cardiomyopathy
Peripartum cardiomyopathy and the obstetric care provider
Peripartum cardiomyopathy (PPCM) is a clinical diagnosis of exclusion defined as heart failure with a reduced ejection fraction towards the end of pregnancy or in the immediate postpartum period. This seemingly simple definition is challenged by the complexities of caring for patients in the third trimester of pregnancy and postpartum. Physiological dyspnea coupled with the other hallmark cardiovascular adaptations of pregnancy can confound the clinical presentation, and the overlap of PPCM with other obstetric and cardiovascular diagnoses further complicate the diagnostic dilemma. Despite these challenges, the increasing contribution of both cardiovascular disease and cardiomyopathy to maternal mortality highlights the importance of a framework for diagnosis and management of the disease.
For an in-depth review, read a chapter summary here.
Continue reading this chapter via PDF below:
Download Issue : Vol 66 No 1